Carlsmed, Inc. Increase (Decrease) in Accounts Payable
Carlsmed, Inc. (CARL) reported Increase (Decrease) in Accounts Payable of -$861.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- Carlsmed, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $670.00K, a 17.34% increase year-over-year.
- Carlsmed, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.53M.
- Carlsmed, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.64M.
- Carlsmed, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $682.00K.
- Carlsmed, Inc. increase (decrease) in accounts payable for fiscal 2025 was $2.32M, a 682.15% increase from fiscal 2024.
- Carlsmed, Inc. increase (decrease) in accounts payable for fiscal 2024 was $297.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $670.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$861.00K 10-Q · filed 2026-08-05 | $779.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.46M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$1.53M 10-Q · filed 2026-05-05 | $109.00K derived: sum of 2 quarters · filed 2026-05-05 | $791.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.36M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.32M derived: sum of 2 quarters · filed 2026-02-25 | $2.89M derived: sum of 3 quarters · filed 2026-08-05 | $2.32M 10-K · filed 2026-02-25 |
| 2025-09-30 | $682.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.25M derived: sum of 2 quarters · filed 2026-08-05 | $683.00K 10-Q · filed 2025-11-06 | $148.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $571.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.00K 10-Q · filed 2026-08-05 | -$534.00K derived: sum of 3 quarters · filed 2026-08-05 | -$645.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$570.00K 10-Q · filed 2026-05-05 | -$1.10M derived: sum of 2 quarters · filed 2026-05-05 | -$1.22M derived: sum of 3 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$646.00K derived: sum of 2 quarters · filed 2026-02-25 | $297.00K 10-K · filed 2026-02-25 | |
| 2024-09-30 | -$111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $832.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $943.00K 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |